To elucidate the biological function of OLFML2A in triple-negative breast cancer cells, we engineered MDA-MB-231 cell line variants with either knockout (KO) or overexpression (OE) of OLFML2A. The gene discussed is OLFML2A; the disease is triple-negative breast carcinoma.